Resolution of fibrosis in mdx dystrophic mouse after oral consumption of N-163 strain of Aureobasidium pullulans produced β-glucan

Recent advances in the management of Duchenne muscular dystrophy (DMD), such as exon skipping and gene therapy, though have reached a clinical stage, the outcome at its best is still considered suboptimal. In this study, we evaluated a novel N-163 strain of Aureobasidium pullulans produced β-glucan ...

Descripción completa

Detalles Bibliográficos
Autores principales: Preethy, Senthilkumar, Aoki, Yoshitsugu, Minegishi, Katsura, Iwasaki, Masaru, Senthilkumar, Rajappa, Abraham, Samuel J. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562469/
https://www.ncbi.nlm.nih.gov/pubmed/37813938
http://dx.doi.org/10.1038/s41598-023-44330-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562469/
https://www.ncbi.nlm.nih.gov/pubmed/37813938
http://dx.doi.org/10.1038/s41598-023-44330-0

Ejemplares similares